Which drug best prevents eye muscle weakness from spreading? new study aims to find out
NCT ID NCT04182984
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 200 adults with new-onset ocular myasthenia gravis, a condition that causes droopy eyelids and double vision. Researchers will compare different treatments, including steroids and immunosuppressants like azathioprine and tacrolimus, to see which works best and has the fewest side effects. The goal is to find the best way to keep the disease from spreading to other muscles and to improve daily life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Immunosuppressants (azathioprine, tacrolimus, mycophenolate mofetil), steroids, and symptomatic treatment (pyridostigmine bromide)
- What this could lead to
- If successful, this study could help identify which immunosuppressant works best for ocular myasthenia gravis, potentially reducing the risk of the disease spreading to other muscles.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be influenced by patient and doctor choices. The findings may not apply to all patients, and immunosuppressants carry risks like infection and organ toxicity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR MYASTHENIA GRAVIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tangdu Hospotal
RECRUITINGXi'an, Shaanxi, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.